Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study

被引：0
|
作者：
Francisco Robert
Alan Sandler
Joan H. Schiller
Glenn Liu
Karen Harper
Lev Verkh
Xin Huang
Jennifer Ilagan
Lesley Tye
Richard Chao
Anne M. Traynor
机构：
[1] University of Alabama at Birmingham,
[2] Comprehensive Cancer Center,undefined
[3] Oregon Health & Science University,undefined
[4] University of Texas Southwestern,undefined
[5] Division of Hematology and Oncology,undefined
[6] University of Wisconsin Carbone Cancer Center,undefined
[7] Pfizer Inc,undefined
[8] Global Research and Development,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2010年 / 66卷
关键词：
Sunitinib; Docetaxel; Solid tumors; Phase I; NSCLC; Antiangiogenesis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：669 / 680
页数：11
相关论文
共 50 条
  • [21] Sunitinib in combination with paclitaxel plus carboplatin in patients with advanced solid tumors: phase I study results
    Elisabeth I. Heath
    George R. Blumenschein
    Roger B. Cohen
    Patricia M. LoRusso
    Noelle K. LoConte
    Sindy T. Kim
    Ana Ruiz-Garcia
    Richard C. Chao
    George Wilding
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 703 - 712
  • [22] Sunitinib combined with pemetrexed and carboplatin in patients with advanced solid malignancies-results of a phase I dose-escalation study
    Blais, Normand
    Camidge, D. Ross
    Jonker, Derek J.
    Soulieres, Denis
    Laurie, Scott A.
    Diab, Sami G.
    Ruiz-Garcia, Ana
    Thall, Aron
    Zhang, Ke
    Chao, Richard C.
    Chow, Laura Q.
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (06) : 1487 - 1498
  • [23] A Phase I dose-escalation study of afatinib combined with nintedanib in patients with advanced solid tumors
    Gordon, Michael S.
    Springett, Gregory M.
    Su, Yungpo Bernard
    Ould-Kaci, Mahmoud
    Wind, Sven
    Zhao, Yihua
    LoRusso, Patricia M.
    FUTURE ONCOLOGY, 2015, 11 (10) : 1479 - 1491
  • [24] A dose escalation study of docetaxel plus capecitabine in combination with gemcitabine in patients with advanced solid tumors
    Amarantidis, K.
    Houhouli, K.
    Papatheodorou, K.
    Miloussis, A.
    Matthaios, D.
    Chatzaki, E.
    Lyrantzopoulos, N.
    Tsaroucha, A.
    Tentes, A.
    Kakolyris, S.
    ONCOLOGY RESEARCH, 2006, 16 (06) : 281 - 287
  • [25] A dose escalation study of weekly docetaxel in patients with advanced solid tumors
    Kouroussis, C
    Agelaki, S
    Mavroudis, D
    Souglakos, J
    Kakolyris, S
    Kalbakis, K
    Vardakis, N
    Reppa, D
    Hatzidaki, D
    Samonis, G
    Georgoulias, V
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 46 (06) : 488 - 492
  • [26] Sunitinib in combination with paclitaxel plus carboplatin in patients with advanced solid tumors: phase I study results
    Heath, Elisabeth I.
    Blumenschein, George R., Jr.
    Cohen, Roger B.
    LoRusso, Patricia M.
    LoConte, Noelle K.
    Kim, Sindy T.
    Ruiz-Garcia, Ana
    Chao, Richard C.
    Wilding, George
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (03) : 703 - 712
  • [27] A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with pemetrexed in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer
    L. Q. M. Chow
    N. Blais
    D. J. Jonker
    S. A. Laurie
    S. G. Diab
    C. Canil
    M. McWilliam
    A. Thall
    A. Ruiz-Garcia
    K. Zhang
    L. Tye
    R. C. Chao
    D. R. Camidge
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 709 - 722
  • [28] A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with pemetrexed in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer
    Chow, L. Q. M.
    Blais, N.
    Jonker, D. J.
    Laurie, S. A.
    Diab, S. G.
    Canil, C.
    McWilliam, M.
    Thall, A.
    Ruiz-Garcia, A.
    Zhang, K.
    Tye, L.
    Chao, R. C.
    Camidge, D. R.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (03) : 709 - 722
  • [29] A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors
    Luis E. Raez
    Kyriakos Papadopoulos
    Alejandro D. Ricart
    E. Gabriella Chiorean
    Robert S. DiPaola
    Mark N. Stein
    Caio M. Rocha Lima
    James J. Schlesselman
    Khaled Tolba
    Virginia K. Langmuir
    Stewart Kroll
    Donald T. Jung
    Metin Kurtoglu
    Joseph Rosenblatt
    Theodore J. Lampidis
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 523 - 530
  • [30] A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumors
    de Braud, F.
    Cascinu, S.
    Spitaleri, G.
    Pilz, K.
    Clementi, L.
    Liu, D.
    Sikken, P.
    De Pas, T.
    ANNALS OF ONCOLOGY, 2015, 26 (11) : 2341 - 2346
12345